ClinicalTrials.gg
RecruitingNCT07906808Updated Oct 30, 2026

Effect of Ultrasonic and Diode Laser Activated Irrigation on Postoperative Pain Following Root Canal Treatment

An interventional study of diode laser activation irrigation and Ultrasonic irrigation activation in Symptomatic Irreversible Pulpitis and Symptomatic Apical Periodontitis, sponsored by October 6 University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by October 6 University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2026, registered Oct 2026).
  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The study is designed to determine whether activation of the irrigant using ultrasonic or diode laser technology can reduce postoperative pain and influence Substance P levels compared with conventional needle irrigation. The findings may contribute to establishing evidence-based irrigation activation protocols for improving patient comfort following root canal treatment.

02

Conditions studied

  • Symptomatic Irreversible Pulpitis and Symptomatic Apical Periodontitis

Keywords

  • Ultrasonic
  • Diode laser
  • Irrigation
  • Activation
03

In context

Lead sponsor

October 6 University is the lead sponsor of 144 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy patients ranging between 18 and 65 years in age .
  2. Patients that experienced moderate-to-severe pain (4-10)-represented on a visual analogue scale (VAS).
  3. Having a mandibular single rooted premolar tooth with vital pulp.
  4. Having the symptoms of symptomatic irreversible pulpitis and apical periodontitis.

Exclusion criteria

Exclusion

  1. Patients who were pregnant or lactating.
  2. Patients taking analgesic or anti-inflammatory drugs within the least 12 hours.
  3. Teeth with calcified root canals, resorptions.
  4. Previously root canal treated.
  5. severe damage and associated traumatic occlusion.
  6. Teeth with open apices.
  7. Presence of periodontal pockets >3 mm in the affected tooth.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Conventional needle irrigation

    The control group will receive conventional needle irrigation during root canal treatment without additional irrigant activation.

  • Experimental
    Ultrasonic irrigation activation

    ultrasonic-activated irrigation using the Ultra X ultrasonic activation device (Eighteeth).

    Procedure: Ultrasonic irrigation activation

  • Experimental
    Diode laser irrigation activation

    This group will receive diode laser-activated irrigation using a 940-nm diode laser (Epic X, BIOLASE)

    Procedure: diode laser activation irrigation

Interventions

  • Procedurediode laser activation irrigation

    This group will receive diode laser-activated irrigation using a 940-nm diode laser (Epic X, BIOLASE).

  • ProcedureUltrasonic irrigation activation

    This group will receive ultrasonic-activated irrigation using the Ultra X ultrasonic activation device (Eighteeth).

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Postoperative pain will be assessed using a Visual Analog Scale (VAS) following conventional root canal treatment. Pain will be recorded at baseline before treatment and at predetermined postoperative time points to compare pain levels among the conventional needle irrigation, ultrasonic-activated irrigation using Ultra X, and 940-nm diode laser-activated irrigation using Epic X groups.

    Time frame: 12,24,48 hours

Secondary outcomes

  1. Substance P level

    Substance P levels will be measured using an enzyme-linked immunosorbent assay (ELISA) to evaluate the effects of conventional needle irrigation, ultrasonic-activated irrigation using Ultra X, and 940-nm diode laser-activated irrigation using Epic X on Substance P levels. Measurements will be performed at the time points specified in the study protocol, and the results will be compared among the three study groups.

    Time frame: up to 24 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Oct 30, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 15, 2026
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07906808
Responsible party
Alaa Hani Omaria (Researcher, October 6 University) — Principal investigator
First posted
Oct 30, 2026
Start date
Jun 1, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Oct 30, 2026

Study contacts

Alaa Hani Omaria, Master degree candidate
Contact
Omariaalaa86@gmail.com
00201507070244
Mohsen Abielhasan, Dean
Contact
Dean@o6u.edu.eg
0020238362488

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion